# Fluticasone furoate + Umeclidinium + Vilanterol

## Trelegy Ellipta 92/55/22 mcg Inhalation Powder

| 藥物代碼           | ETRE                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Chronic obstructive pulmonary disease                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 副作用             | 1% to 10%: Headache (4%), voice disorder (>=1%), Diarrhea (2%), dysgeusia (2%), constipation (>=1%), oral candidiasis (>=1%), gastroenteritis (1%), Urinary tract infection (>=1%), Influenza (>=1%), Back pain (4%), arthralgia (>=1%), Pneumonia (8%), bronchitis (>=1%), pharyngitis (>=1%), rhinitis (>=1%), sinusitis (>=1%), upper respiratory tract infection (>=1%), cough (1%), oropharyngeal pain (1%)Frequency not defined:Paradoxical bronchospasm<1%, postmarketing, and/or case reports: Anaphylaxis |
| 禁忌               | Hypersensitivity to fluticasone, umeclidinium, vilanterol, or any component of the formulation; severe hypersensitivity to milk proteins                                                                                                                                                                                                                                                                                                                                                                           |
| 藥物保存方式       | 30度C以下                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 用法用量           | Oral inhalation: Dry powder inhaler: One inhalation (fluticasone furoate 100 mcg/umeclidinium 62.5 mcg/vilanterol 25 mcg) once daily (maximum dose: 1 inhalation/day)                                                                                                                                                                                                                                                                                                                                              |
| 肝功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 懷孕用藥危分級     | 尚未確立                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 孕期用藥建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 附帶說明           | [仿單] 只有再潛在效益超越beta作用劑干擾子宮收縮作用方面之可能風險的情況下, 才可於懷孕後期與分娩期間使用. FLUTICASONE PREGNANCY RECOMMENDATION: Compatible 其他成分無資料                                                                                                                                                                                                                                                                                                                                           |
| 哺乳期用藥建議     | Unknown 尚未建立                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 附帶說明           | [仿單](節錄) 目前無人類資料,動物實驗資料Umeclidinium會進入乳汁. FLUTICASONE BREASTFEEDING RECOMMENDATION: No Human Data—Probably Compatible 其他成分無資料                                                                                                                                                                                                                                                                                                                                                         |
| 注射劑給藥建議途徑 | INHL                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 注意事項           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |

